BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6765400)

  • 1. Inhibitors of bacterial urease: microbiological considerations on hydroxyurea influenza virus.
    Perrone G; Ferrari C; Arghittu M
    Boll Ist Sieroter Milan; 1982; 61(6):513-5. PubMed ID: 6765400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of bacterial urease.
    Griffith DP; Musher DM; Campbell JW
    Invest Urol; 1973 Nov; 11(3):234-8. PubMed ID: 4201416
    [No Abstract]   [Full Text] [Related]  

  • 3. Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression.
    Fernández A; Gil E; Cartelle M; Pérez A; Beceiro A; Mallo S; Tomás MM; Pérez-Llarena FJ; Villanueva R; Bou G
    J Antimicrob Chemother; 2007 May; 59(5):841-7. PubMed ID: 17332005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Urease Enzyme Production and some Other Virulence Factors Expression in Proteus mirabilis by N-Acetyl Cysteine and Dipropyl Disulphide.
    Abdel-Baky RM; Ali MA; Abuo-Rahma GEAA; AbdelAziz N
    Adv Exp Med Biol; 2017; 973():99-113. PubMed ID: 28190143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of bacterial adherence in urinary tract infections].
    Gromska W
    Postepy Hig Med Dosw; 1985; 39(3):245-63. PubMed ID: 2870490
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of crystallization caused by Proteus mirabilis during the development of infectious urolithiasis by various phenolic substances.
    Torzewska A; Rozalski A
    Microbiol Res; 2014; 169(7-8):579-84. PubMed ID: 24239192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urease activity of bacteria in urine].
    Arai Y; Takeuchi H; Tomoyoshi T; Tatewaki K
    Hinyokika Kiyo; 1989 Feb; 35(2):277-81. PubMed ID: 2500012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of media containing chromogenic substrates for the identification and the listing of urinary bacteria].
    Martin C; Orenga S; Doleans F; Denis F
    Pathol Biol (Paris); 1995 Nov; 43(9):749-53. PubMed ID: 8746095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of ascending pyelonephritis in mice by urease inhibitors.
    Aronson M; Medalia O; Griffel B
    Nephron; 1974; 12(2):94-104. PubMed ID: 4600535
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urease. The primary cause of infection-induced urinary stones.
    Griffith DP; Musher DM; Itin C
    Invest Urol; 1976 Mar; 13(5):346-50. PubMed ID: 815197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tract pathogens in complicated infection and in elderly individuals.
    Nicolle LE
    J Infect Dis; 2001 Mar; 183 Suppl 1():S5-8. PubMed ID: 11171003
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum and urinary cefpodoxime levels and time killing curves performed in the urine of children presenting urinary tract infections.
    Casellas JM; Tome G; Exeni R; Grimoldi I; Goldberg M; Farinati AE
    Pathol Biol (Paris); 1993 Apr; 41(4):385-91. PubMed ID: 8233640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid-mediated cephalosporinase ACC-1 in clinical isolates of Proteus mirabilis and Escherichia coli.
    Girlich D; Karim A; Spicq C; Nordmann P
    Eur J Clin Microbiol Infect Dis; 2000 Nov; 19(11):893-5. PubMed ID: 11152321
    [No Abstract]   [Full Text] [Related]  

  • 15. Design, synthesis, molecular docking, anti-Proteus mirabilis and urease inhibition of new fluoroquinolone carboxylic acid derivatives.
    Abdullah MA; Abuo-Rahma GE; Abdelhafez EM; Hassan HA; Abd El-Baky RM
    Bioorg Chem; 2017 Feb; 70():1-11. PubMed ID: 27908539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug resistance and proticinogenic types of Proteus mirabilis isolated from urinary tract infections].
    Szymaniak L; Aleksandrowicz I; Giedrys-Kalemba S
    Med Dosw Mikrobiol; 1999; 51(3-4):323-30. PubMed ID: 10803261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benurestat, a urease inhibitor for the therapy of infected ureolysis.
    Andersen JA
    Invest Urol; 1975 Mar; 12(5):381-6. PubMed ID: 1089613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germa-gamma-lactones as novel inhibitors of bacterial urease activity.
    Amtul Z; Follmer C; Mahboob S; Atta-Ur-Rahman ; Mazhar M; Khan KM; Siddiqui RA; Muhammad S; Kazmi SA; Choudhary MI
    Biochem Biophys Res Commun; 2007 May; 356(2):457-63. PubMed ID: 17367756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ureaplasma urealyticum-induced crystallization of magnesium ammonium phosphate and calcium phosphates in synthetic urine.
    Grenabo L; Brorson JE; Hedelin H; Pettersson S
    J Urol; 1984 Oct; 132(4):795-9. PubMed ID: 6381769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
    Khan AU; Musharraf A
    Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.